-
Loading metrics
Open Access
Peer-reviewed
Research Article
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
-
Yan Guo,
Affiliation Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America
⨯ -
Shaneda Warren Andersen,
Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Xiao-Ou Shu,
Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Kyriaki Michailidou,
Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
⨯ -
Manjeet K. Bolla,
Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
⨯ -
Qin Wang,
Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
⨯ -
Montserrat Garcia-Closas,
Affiliations Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom, Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom
⨯ -
Roger L. Milne,
Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia
⨯ -
Marjanka K. Schmidt,
Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands
⨯ -
Jenny Chang-Claude,
Affiliations Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany
⨯ -
Allison Dunning,
Affiliation Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom
⨯ -
Stig E. Bojesen,
Affiliations Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark, Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark
⨯ -
Habibul Ahsan,
Affiliation Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America
⨯ -
Kristiina Aittomäki,
Affiliation Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
⨯ -
Irene L. Andrulis,
Affiliations Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada, Department of Molecular Genetics, University of Toronto, Toronto, Canada
⨯ -
Hoda Anton-Culver,
Affiliation Department of Epidemiology, University of California Irvine, Irvine, California, United States of America
⨯ -
Volker Arndt,
Affiliation Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Matthias W. Beckmann,
Affiliation Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America
⨯ -
Alicia Beeghly-Fadiel,
Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Javier Benitez,
Affiliations Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain, Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain
⨯ -
Natalia V. Bogdanova,
Affiliation Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
⨯ -
Bernardo Bonanni,
Affiliation Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy
⨯ -
Anne-Lise Børresen-Dale,
Affiliations Department of Genetics, Institute for Cancer Research, Radiumhospitalet, Oslo University Hospital, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Judith Brand,
Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
⨯ -
Hiltrud Brauch,
Affiliations German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany, University of Tübingen, Tübingen, Germany
⨯ -
Hermann Brenner,
Affiliations Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany, Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Thomas Brüning,
Affiliation Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany
⨯ -
Barbara Burwinkel,
Affiliations Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Graham Casey,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Georgia Chenevix-Trench,
Affiliation Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
⨯ -
Fergus J. Couch,
Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
⨯ -
Angela Cox,
Affiliation Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, United Kingdom
⨯ -
Simon S. Cross,
Affiliation Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom
⨯ -
Kamila Czene,
Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
⨯ -
Peter Devilee,
Affiliation Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
⨯ -
Thilo Dörk,
Affiliation Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
⨯ -
Martine Dumont,
Affiliation Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada
⨯ -
Peter A. Fasching,
Affiliations Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America
⨯ -
Jonine Figueroa,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America
⨯ -
Dieter Flesch-Janys,
Affiliations Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⨯ -
Olivia Fletcher,
Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom
⨯ -
Henrik Flyger,
Affiliation Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark
⨯ -
Florentia Fostira,
Affiliation Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research "Demokritos", Athens, Greece
⨯ -
Marilie Gammon,
Affiliation Departments of Epidemiology, University of North Carolina Chapel-Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Graham G. Giles,
Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia
⨯ -
Pascal Guénel,
Affiliations Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France, University Paris-Sud, Villejuif, France
⨯ -
Christopher A. Haiman,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Ute Hamann,
Affiliation Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Maartje J. Hooning,
Affiliation Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
⨯ -
John L. Hopper,
Affiliation Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia
⨯ -
Anna Jakubowska,
Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
⨯ -
Farzana Jasmine,
Affiliation Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America
⨯ -
Mark Jenkins,
Affiliation Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia
⨯ -
Esther M. John,
Affiliations Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America
⨯ -
Nichola Johnson,
Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom
⨯ -
Michael E. Jones,
Affiliation Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
⨯ -
Maria Kabisch,
Affiliation Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Muhammad Kibriya,
Affiliation Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America
⨯ -
Julia A. Knight,
Affiliations Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada, Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
⨯ -
Linetta B. Koppert,
Affiliation Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
⨯ -
Veli-Matti Kosma,
Affiliations Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland
⨯ -
Vessela Kristensen,
Affiliations Department of Genetics, Institute for Cancer Research, Radiumhospitalet, Oslo University Hospital, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway
⨯ -
Loic Le Marchand,
Affiliation University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America
⨯ -
Eunjung Lee,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Jingmei Li,
Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
⨯ -
Annika Lindblom,
Affiliation Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
⨯ -
Robert Luben,
Affiliation Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
⨯ -
Jan Lubinski,
Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
⨯ -
Kathi E. Malone,
Affiliation Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Arto Mannermaa,
Affiliations Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland
⨯ -
Sara Margolin,
Affiliation Department of Oncology – Pathology, Karolinska Institutet, Stockholm, Sweden
⨯ -
Frederik Marme,
Affiliations National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany
⨯ -
Catriona McLean,
Affiliation Anatomical Pathology, The Alfred Hospital, Melbourne, Australia
⨯ -
Hanne Meijers-Heijboer,
Affiliation Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
⨯ -
Alfons Meindl,
Affiliation Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany
⨯ -
Susan L. Neuhausen,
Affiliation Beckman Research Institute of City of Hope, Duarte, California, United States of America
⨯ -
Heli Nevanlinna,
Affiliation Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
⨯ -
Patrick Neven,
Affiliation Department of Oncology, University Hospital Gasthuisberg, Leuven, Belgium
⨯ -
Janet E. Olson,
Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
⨯ -
Jose I. A. Perez,
Affiliation Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain
⨯ -
Barbara Perkins,
Affiliation Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
⨯ -
Paolo Peterlongo,
Affiliation IFOM, Fondazione Istituto FIRC (Italian Foundation of Cancer Research) di Oncologia Molecolare, Milan, Italy
⨯ -
Kelly-Anne Phillips,
Affiliations Peter MacCallum Cancer Center, The University of Melbourne, Melbourne, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia, Department of Medicine, St Vincent’s Hospital, The University of Melbourne, Fitzroy, Australia
⨯ -
Katri Pylkäs,
Affiliation Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu, Finland
⨯ -
Anja Rudolph,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Regina Santella,
Affiliations Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America, Department of Environmental Health Sciences, Mailman School of Public Health of Columbia University, New York, New York, United States of America
⨯ -
Elinor J. Sawyer,
Affiliation Research Oncology, Guy’s Hospital, King's College London, London, United Kingdom
⨯ -
Rita K. Schmutzler,
Affiliations Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany, Center for Molecular Medicine, University Hospital of Cologne, Cologne, Germany, Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany
⨯ -
Caroline Seynaeve,
Affiliation Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
⨯ -
Mitul Shah,
Affiliation Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
⨯ -
Martha J. Shrubsole,
Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Melissa C. Southey,
Affiliation Department of Pathology, The University of Melbourne, Melbourne, Australia
⨯ -
Anthony J. Swerdlow,
Affiliations Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom
⨯ -
Amanda E. Toland,
Affiliation Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Ian Tomlinson,
Affiliation Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
⨯ -
Diana Torres,
Affiliation Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Thérèse Truong,
Affiliations Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France, University Paris-Sud, Villejuif, France
⨯ -
Giske Ursin,
Affiliation Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
⨯ -
Rob B. Van Der Luijt,
Affiliation Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
⨯ -
Senno Verhoef,
Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands
⨯ -
Alice S. Whittemore,
Affiliation Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America
⨯ -
Robert Winqvist,
Affiliations Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu, Finland, Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland
⨯ -
Hui Zhao,
Affiliations Vesalius Research Center, Leuven, Belgium, Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium
⨯ -
Shilin Zhao,
Affiliation Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America
⨯ -
Per Hall,
Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
⨯ -
Jacques Simard,
Affiliation Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada
⨯ -
Peter Kraft,
Affiliations Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
Paul Pharoah,
Affiliations Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
⨯ -
David Hunter,
Affiliations Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
Douglas F. Easton,
Affiliations Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
⨯ - [ ... ],
-
Wei Zheng
* E-mail: wei.zheng@vanderbilt.edu
Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ - [ view all ]
- [ view less ]
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
- Yan Guo,
- Shaneda Warren Andersen,
- Xiao-Ou Shu,
- Kyriaki Michailidou,
- Manjeet K. Bolla,
- Qin Wang,
- Montserrat Garcia-Closas,
- Roger L. Milne,
- Marjanka K. Schmidt,
- Jenny Chang-Claude
- Published: August 23, 2016
- https://doi.org/10.1371/journal.pmed.1002105